BackClearPoint Neuro Overview

ClearPoint Neuro Total Current Liabilities

ClearPoint Neuro's total current liabilities is $9.5M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$9.48M
38.07% YoYΔ $2.61M vs prior year quarter

Peer average

Loading

ClearPoint Neuro Total Current Liabilities History

Loading

ClearPoint Neuro vs. peers: Total Current Liabilities Comparison

Loading

ClearPoint Neuro Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

ClearPoint Neuro (CLPT) FAQ

ClearPoint Neuro (CLPT) currently reports a total current liabilities of $9.5M as of March 2026. That compares with $6.9M in the prior-year period — up 38.1% year over year. Use the charts on this page to explore ClearPoint Neuro's total current liabilities history and peer comparisons.

ClearPoint Neuro's total current liabilities increased from $6.9M to $9.5M — a 38.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ClearPoint Neuro reported $9.5M in total current liabilities as of March 2026. That compares with $6.9M in the prior-year period — up 38.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $9.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ClearPoint Neuro, and consider following CLPT for alerts when major investors trade the stock.

ClearPoint Neuro is classified in the Healthcare sector. On total current liabilities, it currently shows $9.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLPT with unrelated industries.